Brand Name(s): Fludara
CAS nº: 75607-67-9
(flu dah rah been)
What is Fludarabine?
Fludarabine is a cancer (antineoplastic) medication. It is used to treat chronic lymphocytic leukemia (CLL), a type of blood cancer. It is more commonly known by its brand name, Fludara®.
Fludarabine belongs to the group of medicines called antimetabolites. These type of medications work by interfering with the genetic material (DNA) inside the cancer cells and prevent them from further dividing and growing into more cancer cells.
Latest News
Xanthus Announces Oral Fludarabine NDA Accepted for Review by U.S. FDA
Xanthus Pharmaceuticals, Inc., a privately-held oncology and autoimmune disease drug development...
[more]Protherics and Advancell start Acadra(TM) clinical study in B-cell chronic lymphocytic leukaemia
Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused...
[more]Xanthus Pharmaceuticals Expands Oncology Pipeline with Late-Stage Oral Fludarabine from Schering AG
Xanthus Embarks on Path for Commercialization in the United States
[more]Nipent®, Cytoxan® and Rituxan® Effective for Untreated Poor Risk CLL
Researchers from Ohio State University and the Mayo Clinic have reported that the treatment...
[more]Genta Receives Special Protocol Assessment from FDA for Confirmatory Trial of Genasense(R) Plus Chemotherapy in Chronic Lymphocytic Leukemia
Randomized Trial to Evaluate Fludarabine and Rituximab with or without Genasense in Previously...
[more]